KRONOS ADVANCED TECHNOLOGIES announces Dr. Vladimir Gorobets as Senior Technology Adviser Kronos veteran will lead the company’s technology & innovation development globally

Press Release | 03/05/2020

Los Angeles, California/ March 5, 2020. /OTCMARKETS/- KRONOS ADVANCED TECHNOLOGIES, Inc., (OTC:KNOS) (“KNOS” or the “Company”) a product development and production company that has significantly changed the way air is moved, filtered and sterilized and is focused on developing the Company’s air purification technology products announced today the appointment of Dr. Vladimir Gorobets as the companys Senior Technology Adviser. Dr Gorobets will oversee Kronoss global technology strategy, leading the companys continued innovations in air filtration and other advanced technology developments. He was employed as a Senior Engineer with Kronos from 2000 to 2008 and was the lead inventor and responsible for the majority of Companys issued patents. His IP portfolio includes 41 patents and publications, including 12 US patents and 22 International patents.

Vladimir is a stellar technology leader who, for over 20 years, has driven technological innovations for several companies , including Kronos said Julius Toth, COO. As our business continues to evolve in new ways, we are excited to add his wealth of experience and believe it will be invaluable for us in support of our mission of delivering clean indoor air filtration devices , free from pollutants, bacteria and viruses.

Widely recognized as a transformative technology adviser, Dr Gorobets re-joins Kronos from Research and Development Centre of Smart Grid, Russia where he was CTO, leading all technology and operations — Managed 4 Departments, including 17 PhD, 40 Engineers & 21 contract support staff with annual budget of $8.7 million. Prior to that, Vladimir held senior leadership role at Suzhou Beiang Technology, China- overseeing technology development, manufacturing and customer support of environmental protection and air purification systems for residential and industrial applications, as the company expanded globally.

Kronos is in an exciting new phase of growth and is leading in air filtration technology. I look forward to amplifying that success with an innovative technology roadmap, said Dr. Gorobets. I will work together with our product development team and customers to advance our technology and deliver maximum value to our growing consumer base.


Kronos Advanced Technologies, Inc. began operations in 2002 as a product development and production company that significantly changed the way air is moved, filtered and sterilized. Historically, Kronos focused on developing, marketing and selling the Company’s proprietary air movement and purification technology. Serving the Indoor Air Quality (IAQ) market, Kronos technology uses state-of-the-art high voltage process without the use of traditional mechanical fans and filters. Kronos-based products move air silently, filter and purify the air, and reduce energy consumption. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down in size for the cooling of microchips or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in standalone products to move and filter air replacing HEPA and other filtration systems. There are a broad range of additional markets for standalone and embedded Kronos devices. Examples of immediate addressable markets include health care facilities, operating rooms, manufacturing clean rooms and cabins of automobiles and commercial aircraft.

Currently the Company is revisiting its business plan and planning to enter into new market segments but will continue to market air purifiers and other consumer products.

Contact us via: [email protected] or visit

Follow us on Twitter:

Follow us on FaceBook:

Forward looking statements:

Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the OTC Markets at In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Companys ability to raise capital on acceptable terms, if at all, the Companys successful development of its products and the integration into its existing products and the commercial acceptance of the Companys products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.


For inquiries: 323-680-4772

A publicly traded company on OTC markets under the symbol KNOS

2501 Garfield Avenue | Parkersburg, WV 26101